← Browse by Condition
Medical Condition

advanced unresectable hepatocellular carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07175441 Phase 2
Recruiting

Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma

Enrollment
220 pts
Location
United States
Sponsor
Riboscience, LLC.
View Trial →